An alternative start regimen with aripiprazole once-monthly in patients with schizophrenia: population pharmacokinetic analysis of a single-day, two-injection start with gluteal and/or deltoid intramuscular injection
Author:
Affiliation:
1. Otsuka Pharmaceutical Development & Commercialization, Inc, Princeton, NJ, USA
2. H. Lundbeck A/S, Valby, Denmark
3. Otsuka Pharmaceutical Europe Ltd, Wexham, UK
Funder
Otsuka Pharmaceutical Europe Ltd
H. Lundbeck A/S
Otsuka Pharmaceutical Development & Commercialization, Inc
Publisher
Informa UK Limited
Subject
General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/03007995.2021.1965974
Reference24 articles.
1. Catching Up on Schizophrenia
2. The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches
3. Utilization of Long-Acting Antipsychotic Medication in Patient Care
4. The case for long-acting antipsychotic agents in the post-CATIE era
5. Antipsychotic Adherence Over Time Among Patients Receiving Treatment for Schizophrenia
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Population Pharmacokinetics and Dosing Simulations for Aripiprazole 2‐Month Ready‐to‐Use Long‐Acting Injectable in Adult Patients With Schizophrenia or Bipolar I Disorder;Clinical Pharmacology in Drug Development;2024-04-11
2. A case report of LAI two injection start in a 16-year-old adolescent with severe manic episode and comorbid cannabinoid use disorder;Asian Journal of Psychiatry;2024-04
3. Clinical Experience on the Use of a Single-day, Two-injection Start Initiation Regimen of Aripiprazole Once Monthly in Patients With Schizophrenia in Spain: SaTISfy Study;Journal of Psychiatric Practice;2024-03
4. Towards precision medicine of long-acting aripiprazole through population pharmacokinetic modelling;Psychiatry Research;2024-03
5. Switching to long-acting injectable antipsychotics: pharmacological considerations and practical approaches;Expert Opinion on Pharmacotherapy;2023-06-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3